Clinical Protocol and Data Management Core
临床方案和数据管理核心
基本信息
- 批准号:10230158
- 负责人:
- 金额:$ 0.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-02-18 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountabilityAddressAdherenceAdverse eventBudgetsCancer CenterCancer Center Support GrantCaringClinicClinicalClinical Cancer CenterClinical DataClinical InvestigatorClinical ProtocolsClinical ResearchClinical SciencesClinical TrialsClinical Trials NetworkCommunicationCommunity OutreachCommunity RelationsConduct Clinical TrialsConsentContractsDataData CollectionData Management ResourcesData ReportingDevelopmentDevelopment PlansDrug KineticsEducationEducation and OutreachEducational CurriculumEducational workshopEligibility DeterminationEnrollmentEnsureFacultyGoalsHuman ResourcesIndividualIndustryInformed ConsentInstitutional support resourcesInsuranceIntervention TrialInvestigational TherapiesLeadLinguisticsLinkMinorityMonitorNational Clinical Trials NetworkPatient CarePatientsPerformancePharmaceutical PreparationsPharmacodynamicsPhysiciansPoliciesPositioning AttributePreparationPreventionProceduresProcessProtocols documentationReportingResearchResearch PersonnelResourcesSafetySamplingScienceServicesSiteStaff Work LoadStructureSupportive careSystemTherapeuticTimeTrainingTraining and EducationTranslational ResearchTransportationUnderserved PopulationUpdateWomanWorkWorkloadbasecare systemsdata managementdata qualityflexibilityhealth disparityhigh standardinnovationmeetingsmemberminority healthmultidisciplinaryoutreachpoint of careprogramsprotocol developmentquality assuranceresearch studytrendtrial design
项目摘要
Clinical Protocol & Data Management
PROJECT SUMMARY
Clinical Protocol & Data Management (CPDM) functions at Moffitt Cancer Center (MCC) include 1) trial design,
development, and conduct; 2) oversight of safety and compliance; 3) ensuring data quality and education of
personnel; and 4) appropriate accrual of women and minorities. A collaborative team of approximately 190
CPDM professionals provides centralized management and support of all types of clinical trials, including
investigator-initiated (IITs), industry or other sponsor-initiated, Experimental Therapeutics Clinical Trials
Network (ET-CTN), and National Clinical Trials Network (NCTN). CPDM support for members includes:
protocol development; budget development and contracting; regulatory and IND/IDE management; protocol
activation; patient enrollment; coordination of study-related patient care; research drug administration and care
services; correlative science (pharmacokinetics/pharmacodynamics) sample coordination; data collection and
reporting; monitoring of IIT studies and data and safety monitoring through the Protocol Monitoring Committee
(PMC) and Data Safety & Monitoring (DSM) Committee; audit preparation and coordination; minority outreach
and navigation for accrual to clinical trials; clinical trials management system (CTMS, OnCore) administration
and reporting; staff workload management; and staff education and training.
During the review period (FY2011-2015), the CPDM team successfully accrued and coordinated a combined
total of 11,851 patients to clinical interventional trials (therapeutic, prevention, and supportive care), including
accrual at affiliate sites.
CPDM provides centralized safety and compliance oversight to members through timely monitoring of
investigator-initiated interventional trials, coordination of the PMC, and corporate compliance audits of MCC
clinical research trials, policies, and processes. Results of monitoring and audits are utilized by the PMC for
comprehensive review.
MCC has developed and maintains proactive efforts to provide programs and services to women, minorities,
and other underserved populations through culturally and linguistically relevant care, education, and internal
and community outreach. Faculty members conduct research on minority health disparities, informing these
programs and services. In addition, the ACD for Clinical Science and the VP of Diversity and Community
Relations co-lead a multi-disciplinary Minority Clinical Research Committee to address issues related to
minority accrual at MCC. CPDM resources are closely integrated in these efforts.
临床方案与数据管理
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hatem H Soliman其他文献
Hatem H Soliman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hatem H Soliman', 18)}}的其他基金
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 0.45万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 0.45万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 0.45万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 0.45万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 0.45万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 0.45万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 0.45万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 0.45万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 0.45万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 0.45万 - 项目类别:














{{item.name}}会员




